Synbiotic in the management of infantile colic: A randomised controlled trial

Journal of Paediatrics and Child Health

Volumn 50, Issue 10, 2014, Pages 801-805

  Kianifar, Hamidreza ^a   Ahanchian, Hamid ^b   Grover, Zubin ^b   Jafari, Seyedali ^a   Noorbakhsh, Zeinab ^a   Khakshour, Ali ^a   Sedaghat, Majid ^a   Kiani, Mohammadali ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

infantile colic; probiotic; synbiotic

Indexed keywords

FRUCTOOLIGOSACHARIDE; OLIGOSACCHARIDE; PLACEBO; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM INFANTIS; BREAST FEEDING; CLINICAL ARTICLE; COLIC; COLONY FORMING UNIT; CONTROLLED STUDY; CRYING; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFANT DISEASE; INFANTILE COLIC; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; NEWBORN; PHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

BREAST FEEDING; CHI-SQUARE DISTRIBUTION; COLIC; CRYING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SYNBIOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908247473     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12640     Document Type: Article

References (32)

1. Savino F,. Focus on infantile colic. Acta Paediatr. 2007; 96: 1259-1264.
2. Kheir AE,. Infantile colic, facts and fiction Abdelmoneim E. Ital. J. Pediatr. 2012; 38: 34.
3. Szajewska H, Gyrczuk E, Horvath A,. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr. 2013; 162: 257-262.
4. Vandenplas Y, Veereman-Wauters G, De Greef E, et al. Probiotics and prebiotics in prevention and treatment of diseases in infants and children. J. Pediatr. (Rio J) 2011; 87: 292-300.
5. Grajek W, Olejnik A, Sip A,. Probiotics, prebiotics and antioxidants as functional foods. Acta. Biochim. Pol. 2005; 52: 665-671.
6. Kunze WA, Mao YK, Wang B, et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J. Cell. Mol. Med. 2009; 13 (8B): 2261-2270.
7. Wang B, Mao YK, Diorio C, et al. Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol. Motil. 2010; 22: 98-107, e33.
8. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W,. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296: G868-875.
9. Eberl G, Lochner M,. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal. Immunol. 2009; 2: 478-485.
10. Rhoads JM, Fatheree NY, Noroni J, et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J. Pediatrics. 2009; 155: 823-828.
11. Olafsdottir E, Aksnes L, Fluge G, Berstad A,. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with in ammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta. Pædiatr. 2002; 91: 45-50.
12. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH,. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am. J. Clin. Nutr. 2004; 79: 261-267.
13. Savino F, Bailo E, Oggero R, et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr. Allergy Immunol. 2005; 16: 72-75.
14. Savino F, Cresi F, Pautasso S, et al. Intestinal microflora in breastfed colicky and non-colicky infants. Acta. Paediatr. 2004; 93: 825-829.
15. Sung V, Collett S, de Gooyer T, Hiscock H, Tang M, Wake M,. Probiotics to prevent or treat excessive infant crying: systematic review and meta-analysis. JAMA Pediatr. 2013; 167: 1150-1157.
16. Vieira AT, Teixeira MM, Martins FS,. The role of probiotics and prebiotics in inducing gut immunity. Frontiers Immunol. 2013; 4: 445. eCollection 2013. Review.
17. Savino F, Cordisco L, Tarsaco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010; 126: e526-533.
18. Chapman CM, Gibson GR, Rowland I,. In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 2012; 18: 405-413.
19. Xiao-Ming B, Li J, Feng Z-T, et al. Low level of galactooligosaccharide in infant formula stimulated growth of intestinal bifidobacteria and lactobacilli. World J. Gastroenterol. 2008; 14: 6564-6568.
20. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G,. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006; 91: 814-819.
21. Partty A, Luoto R, Kalliomaki M, Salminen S, Isolauri E,. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr. 2013; 163: 1272-1277.
22. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R,. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr. J. 2012; 11: 81.
23. Ahanchian H, Jones CM, Chen Y, Sly PD,. Respiratory viral infections in children with asthma: do they matter and can we prevent them? BMC Pediatr. 2012; 12: 147.
24. Kianifar HR, Farid R, Ahanchian H, Jabbari F, Moghiman T, Sistanian A,. Probiotics in the treatment of acute diarrhea in young children. Iran J. Med. Sci. 2009; 34: 204-207.
25. Heydarian F, Kianifar HR, Ahanchian H, Khakshure A, Seyedi J, Moshirian D,. A comparison between traditional yogurt and probiotic yogurt in non inflammatory acute gastroenteritis. Saudi Med. J. 2010; 31: 280-283.
26. Pfefferle PI, Prescott SL, Kopp M,. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J. Allergy Clin. Immunol. 2013; 131: 1453-1463.
27. Farid R, Ahanchian H, Jabbari F, Moghiman T,. Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iran J. Pediatr. 2011; 21: 225-230.
28. Surono IS, Koestomo FP, Novitasari N, Zakaria FR, Yulianasari, Koesnandar,. Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study. Anaerobe 2011; 17: 496-500.
29. LeBlanc JG, Laino JE, del Valle MJ, et al. B-group vitamin production by lactic acid bacteria-current knowledge and potential applications. J. Appl. Microbiol. 2011; 111: 1297-1309.
30. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI,. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009; 1: 6ra14.
31. Ly NP, Litonjua A, Gold DR, Celedõn JC,. Gut microbiota probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J. Allergy Clin. Immunol. 2011; 127: 1087-1094.
32. Roos S, Dicksved J, Tarasco V, et al. 454 Pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS ONE 2013; 8: e56710.